Recent studies how found evidence that Depo-Provera massively increases the risk of developing brain tumors even after women ...
The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called ...
The plaintiffs bar has argued that courts can only preempt prescription pharmaceutical state law failure-to-warn claims when ...
At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...
Jul. 24, 2025 7:00 AM ETPfizer Inc. (PFE), PFE:CA Mahyar Etminan, one of the authors of ‘the Frey study’, said: “Given the elevated risk of meningioma with medroxyprogesterone, women may opt to ...
Depo-Provera is an injectable form of birth control manufactured by Pfizer that contains a synthetic hormone, medroxyprogesterone acetate, which prevents pregnancy by stopping ovulation, thickening ...
For decades, millions of women have relied on the Depo-Provera birth control shot as a convenient form of long-term contraception. However, growing medical evidence has linked long-term Depo-Provera ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback